Annual CFF
$253.00 K
-$250.00 K-49.70%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual cash flow from financing activities is $253.00 thousand, with the most recent change of -$250.00 thousand (-49.70%) on December 31, 2023.
- During the last 3 years, BOLT annual CFF has fallen by -$39.34 million (-99.36%).
- BOLT annual CFF is now -99.92% below its all-time high of $311.11 million, reached on December 31, 2021.
Performance
BOLT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$79.00 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly cash flow from financing activities is $0.00, with the most recent change of -$79.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, BOLT quarterly CFF has dropped by -$79.00 thousand (-100.00%).
- BOLT quarterly CFF is now -100.00% below its all-time high of $297.02 million, reached on March 31, 2021.
Performance
BOLT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$185.00 K
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, BOLT TTM cash flow from financing activities is $185.00 thousand, unchanged on September 30, 2024.
- Over the past year, BOLT TTM CFF has stayed the same.
- BOLT TTM CFF is now -99.95% below its all-time high of $336.58 million, reached on March 31, 2021.
Performance
BOLT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BOLT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | -100.0% | 0.0% |
| 3 y3 years | -99.4% | -100.0% | 0.0% |
| 5 y5 years | -98.7% | -100.0% | 0.0% |
BOLT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -100.0% | at low | -99.9% | at low |
| 5 y | 5-year | -99.9% | at low | -100.0% | +100.0% | -100.0% | +444.1% |
| alltime | all time | -99.9% | at low | -100.0% | +100.0% | -100.0% | +444.1% |
Bolt Biotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $185.00 K(0.0%) |
| Jun 2024 | - | $79.00 K(-25.5%) | $185.00 K(-26.9%) |
| Dec 2023 | $253.00 K(-49.7%) | $106.00 K(>+9900.0%) | $253.00 K(-13.1%) |
| Sep 2023 | - | $0.00(-100.0%) | $291.00 K(0.0%) |
| Jun 2023 | - | $147.00 K(+2.1%) | $291.00 K(-42.1%) |
| Dec 2022 | $503.00 K(-99.8%) | $144.00 K(>+9900.0%) | $503.00 K(-41.1%) |
| Sep 2022 | - | $0.00(-100.0%) | $854.00 K(-17.8%) |
| Jun 2022 | - | $252.00 K(+135.5%) | $1.04 M(-92.7%) |
| Mar 2022 | - | $107.00 K(-78.4%) | $14.20 M(-95.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $311.11 M(+685.7%) | $495.00 K(+167.6%) | $311.11 M(+0.5%) |
| Sep 2021 | - | $185.00 K(-98.6%) | $309.55 M(+0.4%) |
| Jun 2021 | - | $13.41 M(-95.5%) | $308.44 M(-8.4%) |
| Mar 2021 | - | $297.02 M(<-9900.0%) | $336.58 M(+750.0%) |
| Dec 2020 | $39.60 M(-18.6%) | -$1.06 M(+15.4%) | $39.60 M(-2.6%) |
| Sep 2020 | - | -$923.00 K(-102.2%) | $40.66 M(-2.2%) |
| Jun 2020 | - | $41.55 M(>+9900.0%) | $41.59 M(>+9900.0%) |
| Mar 2020 | - | $34.00 K | $34.00 K |
| Dec 2019 | $48.63 M(+154.7%) | - | - |
| Dec 2018 | $19.09 M | - | - |
FAQ
- What is Bolt Biotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual CFF year-on-year change?
- What is Bolt Biotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly CFF year-on-year change?
- What is Bolt Biotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics TTM CFF year-on-year change?
What is Bolt Biotherapeutics annual cash flow from financing activities?
The current annual CFF of BOLT is $253.00 K
What is the all time high annual CFF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual cash flow from financing activities is $311.11 M
What is Bolt Biotherapeutics annual CFF year-on-year change?
Over the past year, BOLT annual cash flow from financing activities has changed by -$250.00 K (-49.70%)
What is Bolt Biotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BOLT is $0.00
What is the all time high quarterly CFF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly cash flow from financing activities is $297.02 M
What is Bolt Biotherapeutics quarterly CFF year-on-year change?
Over the past year, BOLT quarterly cash flow from financing activities has changed by -$79.00 K (-100.00%)
What is Bolt Biotherapeutics TTM cash flow from financing activities?
The current TTM CFF of BOLT is $185.00 K
What is the all time high TTM CFF for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high TTM cash flow from financing activities is $336.58 M
What is Bolt Biotherapeutics TTM CFF year-on-year change?
Over the past year, BOLT TTM cash flow from financing activities has changed by $0.00 (0.00%)